fda warning letters compounded semaglutide october 2025 National Hispanic Medical Association | After GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA Warns on Certain Forms

Physicians should avoid prescribing it to: Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Individuals with severe gastrointestinal conditions, such as gastroparesis. Patients with a known allergy to GLP-1 receptor agonists. Pregnant or breastfeeding women, unless approved by a physician

At Centered Primary Care, we take a holistic approach to your health

10 GLP-1 clinics in Kissimmee are currently accepting new patients

In 2022 , demand for Wegovy and Ozempic outpaced supply, creating shortages that lasted months and left patients without the medications they had started taking

She had just wanted to finally lose that extra 40 pounds